BioPharmSignal logoBioPharmSignal

Biotech News

AtriCure Reports First Quarter 2026 Financial Results

AtriCure (ATRC)AtriCureEarnings

First Quarter 2026 worldwide revenue of $141.2 million, an increase of 14.3% year over year First Quarter 2026 profitability improved, with net income of $0.1 million and adjusted EBITDA of $17.1 million U.S. revenue growth accelerated to 14.9%, driven by AtriClip FLEX-Mini ®, cryoSPHERE ® MAX ™,

Open original release

Related news

ATRCAtriCure2026-04-14 12:00 EST

AtriCure to Announce First Quarter 2026 Financial Results

IRIXIRIDEX2026-05-19 20:05 EST

Iridex Reports First Quarter 2026 Financial Results

PAVMPAVmed2026-05-14 12:00 EST

Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results

XTNTXtant Medical2026-05-13 11:00 EST

Xtant Medical Reports First Quarter 2026 Financial Results

ICCMIceCure Medical2026-05-12 12:30 EST

IceCure Reports First Quarter 2026 Financial Results: ProSense® Sales Increase Substantially in the U.S. and North America

AORTArtivion2026-05-07 20:05 EST

Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan

SGHTSight Sciences2026-05-06 20:05 EST

Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance

IRIXIRIDEX2026-05-05 20:05 EST

Iridex to Report First Quarter 2026 Financial Results on May 19, 2026

CVRXCVRx2026-04-13 12:00 EST

CVRx Reports Preliminary First Quarter 2026 Financial Results

XAIRBeyond Air2026-06-26 11:00 EST

Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update

View all latest news

AtriCure

AtriCure is a surgical device company focused on atrial fibrillation, left atrial appendage management, and cardiac ablation.

Recent company news

ATRCAtriCure2026-05-27 12:00 EST

AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference

ATRCAtriCure2026-05-05 20:01 EST

AtriCure Reports First Quarter 2026 Financial Results

ATRCAtriCure2026-04-28 12:00 EST

AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference

ATRCAtriCure2026-04-14 12:00 EST

AtriCure to Announce First Quarter 2026 Financial Results

ATRCAtriCure2026-02-24 13:00 EST

AtriCure to Participate in the Citizens Life Sciences Conference

Stock data

Close
37.37 USD
Market cap
1.31B USD
Exchange
NASDAQ
Sector
MedTech
Location
United States